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ABSTRAK
Latar belakang: transfusi darah berulang pada pasien thalassemia menyebabkan penumpukan besi pada 
berbagai organ. Penanda serum untuk kelebihan besi, yaitu feritin serum dan saturasi transferin, bersifat sensitif 
tetapi tidak spesifik. MRI T2-star (T2*) sangat penting untuk mendeteksi kadar besi pada berbagai organ. 
Penelitian ini bertujuan untuk mengetahui derajat hemosiderosis pada berbagai organ, perbedaan derajat 
penumpukkan besi antara anak dan dewasa, serta korelasinya dengan penanda serum untuk kelebihan besi. 
Metode: penelitian ini merupakan penelitian potong lintang terhadap pasien thalassemia yang membutuhkan 
transfusi rutin. Pasien-pasien tersebut menjalani pemeriksaan MRI T2* di RS Cipto Mangunkusumo sejak 2014 
- 2018. Hasil: sebanyak 546 subyek terlibat dalam penelitian ini. Jumlah subyek anak dan dewasa setara. Pada 
umumnya, penumpukan besi di jantung masih dalam batas normal. Perbedaan derajat hemosiderosis jantung 
antara anak dan dewasa signifikan (p=0.009). Evaluasi organ hati menunjukkan umumnya pasien mengalami 
hemosiderosis sedang-berat, dengan perbedaan antara anak dan dewasa yang signifikan (p=0.017). Evaluasi 
organ pankreas menunjukkan umumnya pasien mengalami hemosiderosis ringan dan penumpukan besi di 
pankreas terus meningkat dengan bertambahnya usia. Kadar feritin serum mempunyai korelasi yang lemah 
dengan hasil MRI T2* jantung, korelasi sedang dengan hasil MRI T2* hati dan pankreas. Korelasi saturasi 
transferin dengan hasil MRI T2* pada berbagai organ sangatlah lemah. Kesimpulan: terdapat perbedaan derajat 
hemosiderosis di jantung dan hati yang signifikan antara anak dan dewasa. Hati merupakan organ dengan 
penumpukan besi terbanyak, diikuti oleh pankreas dan jantung. Penumpukan besi di hati dan pankreas sudah 
terjadi sejak anak-anak. Penumpukkan besi di pankreas terus meningkat dengan bertambahnya usia. Kadar 
feritin serum dan saturasi transferin tidak boleh digunakan secara tunggal untuk menilai derajat hemosiderosis 
di berbagai organ. Kami menyarankan agar pemeriksaan MRI T2* minimal dilakukan 1 kali untuk mengetahui 
penumpukan besi di organ.
Kata kunci: talasemia mayor, penumpukan besi, T2 relaxation time, serum feritin, saturasi transferin.
ABSTRACT
Background: routine blood transfusion in transfusion-dependent-thalassemia (TDT) causes iron 
accumulation in various organ. Serum markers of iron overload, serum ferritin and transferrin saturation, are 
sensitive but not specific. MRI T2-star (T2*) is valuable for detecting iron level in organs. This study aimed to 
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explore the degree of iron overload in various organs, iron deposition difference between children and adults, also 
its correlation with serum marker of iron overload. Methods: this was a cross-sectional study of TDT patients 
who had been evaluated by MRI T2* examination in Cipto Mangunkusumo Hospital from 2014 to 2018. Results: 
a total of 546 subjects was included in this study. The number of subjects between children and adults was almost 
equal. Most of subjects had normal cardiac iron deposition. The difference of cardiac iron overload between 
children and adults was significant (p=0.009). Liver evaluation showed that most of subjects had moderate to 
severe iron overload. This difference between children and adults was significant (p=0.017). Pancreas evaluation 
showed that either children or adults mostly had mild pancreatic iron overload. Analysis of T2* showed that 
pancreatic iron deposition progressed with increasing age. Serum ferritin had weak correlation with heart T2* 
MRI, moderate correlation with pancreas and liver T2* MRI. Relationship between transferrin saturation and 
T2* MRI was extremely weak. Conclusion: cardiac and hepatic iron deposition between children and adults 
differ significantly. Liver has the greatest iron overload, followed by pancreas and heart. Iron deposition in 
liver and pancreas has been started from earlier age. Pancreatic iron deposition rises with increasing age. 
Serum ferritin and transferrin saturation should not be used solely to predict iron overload in various organs. 
We suggest that MRI evaluation must be conducted at least once to assess iron deposition in organs.
Keywords: thalassemia major, iron overload, T2 relaxation time, serum ferritin, transferrin saturation.
INTRODUCTION
Thalassemia is a group of inherited blood 
disorder characterized by decrease or absence 
of one or more globin chains. It is the most 
common single gene disorder in the world.  There 
are two main treatments for thalassemia: blood 
transfusion and iron chelation therapy.1
Transfusion-dependent thalassemia (TDT) 
is the term given to individuals with thalassemia 
who require routine blood transfusions. There are 
three main purposes of transfusion in thalassemia: 
improve the anemia; suppress the ineffectiveness 
process of erythropoiesis; and prevent major 
skeletal and neurological complications. The 
excess iron from transfused erythrocytes will be 
accumulated in various organs. In non-transfusion 
dependent thalassemia (NTDT), gastro-intestinal 
absorption of iron increases several folds to 
accommodate the decrease of hemoglobin levels.2 
Iron overload is toxic to cells, causing severe and 
irreversible organ damage.1 
Serum markers of iron overload, serum 
ferritin and transferrin saturation, are inexpensive 
techniques to predict iron concentration in 
the body. Those markers have been widely 
used to determine the needed for starting iron 
chelation therapy and monitoring therapeutic 
response. However, these techniques have many 
shortcomings and cannot be used solely to monitor 
iron levels in the body. They are sensitive but not 
specific. Ferritin as an acute phase reactant will 
increase sharply in the presence of inflammation. 
Patients who got frequent transfusion will have 
fully saturated transferrin.3-5
Magnetic resonance imaging (MRI) is 
valuable for detecting iron levels because it is 
non-invasive, reproducible, accurate, and can 
be used in various organ. The last characteristic 
is important because the ability of iron uptake 
varies in each organ.5 MRI is an expensive 
method, it must be used cost-effectively. In this 
study, we wanted to explore the difference in 
iron deposition between children and adults. The 
result can be used to determine the degree of 
iron overload in various organs and the progress 
of iron deposition with increasing age. We also 
aimed to evaluate the correlation between MRI 
T2* value in specific organs with iron markers 
(serum ferritin and transferrin saturation).
METHODS
This study was a cross-sectional study, 
conducted from 2014 to 2018. Total sampling of 
all subjects (N=546) who had been evaluated by 
MRI T2* examination in Cipto Mangunkusumo 
Hospital were recruited in this study.
This study has been approved by the Ethics 
Committee of Faculty of Medicine Universitas 
Indonesia on June 27th, 2016, with a reference 
number 547/UN2.F1/ETIK/2016.
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Subjects
Subjects were divided into two groups: 
children (≤ 18 years) and adults (> 18 years). We 
assessed three organs, including heart, liver, and 
pancreas. MRI assessment was done using MRI 
Avanto 1.5 Tesla (Siemens Avanto Germany). 
Quantification of T2* value was obtained using 
CMRtoolsTM software (Thalassemia-Tools, 
London, United Kingdom). Liver T2* value 
was determined in the center of the liver using 
a single 10 mm slice at 12 different echo times 
(1.3-23 millisecond=ms). Subjects were asked to 
hold their breath for 11-13 s. Cut-off points of 
iron overload by T2* MRI are as follows: Heart: 
normal >20 ms, mild 14-20 ms, moderate 10-14 
ms, severe <10ms; Liver: normal >6.3 ms, mild 
2.7-6.3 ms, moderate 1.4-2.7 ms, severe <1.4 
ms; Pancreas: normal >33 ms, mild 10-33 ms, 
moderate 2.5-10 ms, severe <2.5 ms.6,7 Blood 
sample was collected to measure serum ferritin 
level (ng/mL) and transferrin saturation (%).
Data Analysis
Data analysis between age groups and degree 
of iron overload was performed using Chi-
square analysis. Correlations between MRI T2* 
value with iron markers (ferritin and transferrin 
saturation) was assessed using Pearson’s 
correlation analysis.
RESULTS
A total of 546 transfusion-dependent 
thalassemia subjects was included in this study. 
We found that the number of TDT subjects 
between male and female were almost equal. The 
number of child subjects (56.4%) was greater 
than adult subjects (43.6%), with only 3.5% of 
total subjects were younger than 9 years. Most 
of the subjects were diagnosed as β-thalassemia 
and β-thalassemia and HbE/β-thalassemia. 
Around 63.7% of them used deferiprone (DFP) 
monotherapy as iron chelator. (Table 1)
Table 2 showed that most of the children 
(89.0%) and adults (82.7%) subject had normal 
iron deposition in the heart. However, cardiac 
iron overload had been observed more common 
in adults than children (p=0.009). The percentage 
of severe iron overload in adult subjects was four 
times greater than children.
The result of liver T2* MRI showed the 
opposite result, of which almost all subjects had 
iron overload in the liver. Only few of children 
(9.4%) and adults (13.4%) still had normal liver 
iron levels. There was significant difference 
of severity degree of iron overload between 
children and adults (p=0.017). Severe hepatic 
iron overload was observed more frequently in 
adults than children (Table 2).
Iron deposition in the pancreas did not 
differ significantly between children and adults 
(p=0.387). Only around a quarter of subjects 
still had normal pancreatic iron deposition. 
Interestingly, most of them had mild pancreatic 
iron overload and only a few of them who had 
severe pancreatic iron overload (Table 2).
Analysis of T2* values (ms) showed that 
iron deposition in pancreas increased with 
increasing age and the peak was reached at 45-
50 years. Meanwhile, analysis of the heart and 
liver showed no specific progressive pattern with 
increasing age (Figure 1). 
Table 3 showed that serum ferritin and 
transferrin saturation were inversely correlated 
Table 1. Subject’s Characteristics
Variables n (%)
Sex
 - Male 277 (50.7)
 - Female 269 (49.3)
Age
 - ≤ 18 y.o 308(56.4)
 - > 18 y.o 238 (43.6)
Type of thalassemia
 - α-thalassemia 16 (2.9)
 - β-thalassemia 257 (47.0)
 - HbE/β-thalassemia 271 (49.6)
 - HbE/α-β-thalassemia 2 (0.3)
Iron chelator
 - Monotherapy
 - DFO 12 (2.2)
 - DFP 348 (63.7)
 - DFX 85 (15.6)
Combination therapy
 - DFO+DFP 35 (6.4)
 - DFO+DFX 10 (1.8)
 - DFP+DFX 47 (8.6)
Without chelation 9 (1.7)
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with T2* MRI. There was only weak relationship 
between serum ferritin and heart T2* MRI. 
Moderate relationship was observed between 
serum ferritin and liver T2* MRI, also serum 
ferritin and pancreas T2* MRI. The correlation 
of transferrin saturation with T2* MRI was 
extremely weak. The scatter plots between those 
values was presented in Figure 2.
DISCUSSION
The gold standard to quantify iron overload 
is direct measurement of iron concentration in 




Normal Mild Moderate Severe 
Cardiac iron deposition
≤ 18 y.o 274 (89.0) 25 (8.1) 5 (1.6) 4 (1.3) 0.009
> 18 y.o 197 (82.7) 18 (7.6) 9 (3.8) 14 (5.9)
Hepatic iron deposition
≤ 18 y.o 29 (9.4) 87 (28.2) 107 (34.7) 85 (27.7) 0.017
> 18 y.o 32 (13.4) 49 (20.6) 69 (29.0) 88 (37.0)
Pancreatic iron deposition
≤ 18 y.o 79 (25.6) 169 (54.9) 57 (18.5) 3 (1.0) 0.387
> 18 y.o 69 (29.0) 121 (50.8) 45 (18.9) 3 (1.3)
Figure 1. Mean T2* MRI value in various organs
Table 3. Correlation coefficients between serum markers of iron overload with T2* MRI
Heart T2*MRI Liver T2*MRI Pancreas T2*MRI
Serum Ferritin - 0.291 - 0.540 - 0.326
Transferrin saturation - 0.138 - 0.080 - 0.031
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Figure 2. Scatter plots of serum markers of iron overload vs T2* MRI.
(Normal iron overload: area on the right side of red line; mild iron overload: area between green and red line; moderate 
iron overload: area between blue and green line; severe iron overload: area on the left side of blue line)
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biopsy specimens using spectrophotometry. 
However, this technique is invasive and only 
available at specialized centers.8 T2* relaxometry 
MRI demonstrated high accuracy and is very 
effective in quantifying iron concentration in 
various organs, especially liver.5
Our study found that only few subjects had 
moderate-severe cardiac iron overload. Leonardi 
et al9 found that low values of T2* myocardial 
was correlated significantly with decreased left 
ventricular ejection fraction (LVEF). T2* value 
<9 ms has high sensitivity (100%) and specificity 
(89%) to diagnose EF <50%. However, its value 
was correlated poorly with diastolic function.
Interestingly, myocard was less affected 
by iron deposition compared to other organs. 
There are two reasons that may explain this 
phenomenon. Firstly, extrahepatic tissues have 
lower kinetic ability of iron uptake because they 
selectively load circulating non-transferrin-
bound iron.10,11 The other reason was almost all 
subjects in our study consumed DFP, around 
63.7% as single iron chelator and 15% as 
combined iron chelator. Deferiprone had been 
proven to be effective in lowering cardiac iron 
stores.12 Even, in some studies it had shown 
improvement in left and right ventricular ejection 
fraction.13
In our study, the trend of pancreatic iron 
deposition rose with increasing age, reaching its 
peak around 45-50 years. Among other organs, 
liver was the most affected organ. Theoretically, 
liver iron concentration describes total body iron 
contents. As the main site of iron storage, liver 
contain almost 70% of total body iron. Therefore, 
it is very valuable to monitor the response of 
therapy.14
The data from our study should arise more 
awareness for further liver examination, such as 
liver elastography. Factor that may contribute 
to increase the risk of hepatic iron overload is 
hepatitis infection. Routine blood transfusion 
increased the risk of transfusion-transmitted 
infection. One of the study in our thalassemia 
center found that the prevalence of positive 
serological markers for hepatitis B, hepatitis C, 
and combination infection were 0.8%, 17.8%, 
and 0.8%, respectively. However, even in the 
absence of hepatitis infection and other cause 
of chronic liver disease, cirrhosis may develop 
from chronic hepatic iron overload.15
Our study showed that only around 20% of 
subjects had moderate to severe pancreatic iron 
overload. Meanwhile, Noetzly LJ, et al16 study 
showed less than 34% of subjects had normal 
to mild pancreatic iron overload. Maybe it 
was because in their study mostly the subjects 
used deferasirox (DFX) as iron chelator (81%), 
whereas in our study mostly the subjects were 
on DFP (63.7%). Deferiprone may improve the 
activity of glucoronyl transferase enzyme.
Pancreas T2* MRI measurement showed that 
most of subjects had mild iron overload, started 
from earlier age. The same result was obtained 
in other Noetzli LJ, et al16 study, which showed 
that pancreatic iron overload occurr nearly a 
decade earlier than cardiac iron overload. This 
information can be very useful to monitor the 
response of iron chelation therapy. If a patient 
has normal cardiac but decreased pancreas T2* 
MRI value, the physician should not wait cardiac 
iron overload appearance to modify or increase 
the chelation therapy.10 It is important because 
cardiac iron overload is the leading cause of 
death in TDT patients.17
In our study we found that serum ferritin 
value could not be used solely to predict the 
degree of iron overload in heart and pancreas 
because the small correlation between those 
values. Serum ferritin may be used to predict 
the degree of hepatic iron overload because 
the correlation was moderate. However, we 
must notice that serum ferritin is an acute phase 
reactant, which is easily affected by any kind of 
inflammation.3 From our study, we also observed 
that transferrin saturation should not be used 
to predict the degree of iron overload in TDT 
patients. Transferrin saturation is defined as the 
percentage of transferrin being occupied by iron, 
which indirectly describes iron overload states 
in the body. However, TDT patients get frequent 
transfusions which cause the iron accumulated 
in body, but it is not followed by the increased 
of iron-binding capacity. Transferrin itself is 
reduced in the presence of any inflammation, 
which is almost unavoidable in thalassemia 
patients.18 Therefore, almost all patients, either 
normal, mild, moderate, or severe iron overload 
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had 100% transferrin saturation. Other markers 
of non-transferrin bound iron (NTBI), like labile 
plasma iron (LPI) may be more useful to predict 
the degree of iron overload and evaluate the 
response of therapy.
Another interesting finding from our study 
was that 1.7% of TDT subjects had never used 
iron chelation. They had normal ferritin value, 
transferrin saturation, and T2*MRI, although 
they got routine transfusion. Certainly, protecting 
factors in this population, such as genetic factors, 
should be explored. It may become target 
treatment of iron overload in future.
CONCLUSION
In conclusion, this study demonstrated 
significant difference of cardiac and hepatic 
iron deposition between children and adults. 
Liver had the greatest iron overload, followed by 
pancreas and heart. Hepatic and pancreatic iron 
overload in transfusion-dependent-thalassemia 
patients had started from earlier age. The trend of 
pancreatic iron deposition rises with increasing 
age. Our findings suggest that serum marker of 
iron overload should not be used solely to predict 
the degree of iron overload. MRI evaluation 
must be conducted at least once to monitor the 
deposition of iron in organs.
REFERENCES
1. Marengo-Rowe AJ. The thalassemias and related 
disorders. Proc (Bayl Univ Med Cent). 2007;20(1):27–
31.
2. Langhi D, Ubiali EMA, Marques JFC, et al. Guidelines 
on Beta-thalassemia major – regular blood transfusion 
therapy: Associação Brasileira de Hematologia, 
Hemoterapia e Terapia Celular: project guidelines: 
Associação Médica Brasileira – 2016. Rev Bras 
Hematol Hemoter. 2016;38(4):341–5.
3. Wang W, Knovich MA, Coffman LG, Torti FM, Torti 
SV. Serum ferritin: past, present, and future. Biochim 
Biophys Acta. 2010;1800(8):760–9.
4. Puliyel M, Sposto R, Berdoukas VA, et al. Ferritin 
trends do not predict changes in total body iron 
in patients with transfusional iron overload. Am J 
Hematol. 2014;89(4):391-4.
5. Echeverria JMA, Castiella A, Emparanza JI. 
Quantification of iron concentration in the liver by 
MRI. Insights Imaging. 2012;3(2):173-80.
6. Eghbali A, Taherahmadi H, Shahbazi M, Bagheri 
B, Ebrahimi L. Association between serum ferritin 
level, cardiac and hepatic T2-star MRI in patients 
with major β-thalassemia. Iran J Ped Hematol Oncol. 
2014;4(1):17-21.
7. Saggar K, Sobti P. MRI assessment of iron overload in 
thalassemia: an overview. Endo-Thal. 2013;11(1):29-
36.
8. Hernando D, Levin YS, Sirlin CB, Reeder SB. 
Quantification of liver iron with MRI: state of the art 
and remaining challenges. J Magn Reson Imaging. 
2014;40(5):1003-21.
9. Leonardi B, Margossian R, Colan SD, Powell 
AJ. Relationship of magnetic resonance imaging 
estimation of myocardial iron to left ventricular 
systolic and diastolic function in thalassemia. JACC 
Cardiovasc Imaging. 2008;1(5):572-8.
10. Noetzli LJ, Papudesi J, Coates TD, Wood JC. 
Pancreatic iron loading predicts cardiac iron loading 
in thalassemia major. Blood. 2009;114(19):4021-6.
11. Noetzli LJ, Carson SM, Nord AS, Coates TD, Wood 
JC. Longitudinal analysis of heart and liver iron in 
thalassemia major. Blood. 2008;112(7):2973-8.
12. Belmont A, Kwiatkowski JL. Deferiprone for the 
treatment of transfusional iron overload in thalassemia. 
Expert Rev Hematol. 2017;10(6):493-503.
13. Berdoukas V, Farmaki K, Carson S, Wood J, Coates T. 
Treating thalassemia major-related iron overload: the 
role of deferiprone. J Blood Med. 2012;3:119-29.
14. Sirlin CB, Reeder SB. Magnetic resonance imaging 
quantification of liver iron. Magn Reson Imaging Clin 
N Am. 2010;18(3):359-ix.
15. Deugnier Y, Turlin B. Pathology of hepatic iron 
overload. World J Gastroenterol. 2007;13(35):4755-60.
16. Noetzli LJ, Mittelman SD, Watanabe RM, Coates TD, 
Wood JC. Pancreatic iron and glucose dysregulation in 
thalassemia major. Am J Hematol. 2012;87(2):155-60.
17. de Montalembert M, Ribeil JA, Brousse V, et al. Cardiac 
iron overload in chronically transfused patients with 
thalassemia, sickle cell anemia, or myelodysplastic 
syndrome. PLoS One. 2017;12(3):e0172147.
18. McLaren CE, Li KT, Gordeuk VR, Hasselblad V, 
McLaren GD. Relationship between transferrin 
saturation and iron stores in the African American 
and US Caucasian populations: analysis of data from 
the third National Health and Nutrition Examination 
Survey. Blood. 2001;98(8):2345-51.
